IPRIPR2025-00603Terminated
Amgen Inc. et al.v.Bristol-Myers Squibb Company
IPR challenge of US 11332529.
Type
IPR
Filed
Feb 28, 2025
Instituted
—
Decided
Oct 1, 2025
Patent
Application
16306290
Inventor
Michael AXELSON
Granted
May 17, 2022
01
Timeline
2 milestones
2025-02-28Petition filed
2025-10-01Terminated
02
Parties & counsel
Petitioner
Amgen Inc. et al.
Counsel
McKeown, Scottet al
Patent Owner
Bristol-Myers Squibb Company
Counsel
Maslowski, Stevenet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →